Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
---|---|---|---|---|---|
![]() | ALVOTECH | 2 | - | +1,02 % | |
![]() | KVIKA BANKI | 1 | - | - | |
![]() | FESTI | - | 4 | - | |
![]() | HEIMAR | - | 3 | - | |
JBT MAREL | - | 2 | 0,00 % | ||
ARION BANK | - | 1 | -0,45 % | ||
![]() | ICELANDAIR GROUP HF | - | - | - | |
![]() | HAGAR | - | - | - | |
![]() | SJOVA | - | - | - | |
![]() | REITIR | - | - | - |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18:42 | Kvika banki hf.: Results of Bond Offering KVIKA 28 0703 | 5 | GlobeNewswire (USA) | ||
15:18 | Alvotech reports positive results in study for Xolair biosimilar | 3 | Seeking Alpha | ||
10:06 | Alvotech: Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair (omalizumab) | 154 | GlobeNewswire (Europe) | REYKJAVIK, ICELAND, PISCATAWAY, NEW JERSEY AND LONDON, UK (June 25, 2025) - Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines... ► Artikel lesen | |
Mo | Nasdaq announces semi-annual changes to the OMX Iceland 15 Index: Eimskipafélag Íslands hf. and Skagi hf. will be added; Kaldalón hf. and Síldarvinnslan hf. will be removed | 95 | GlobeNewswire | Reykjavik, June 23, 2025 - Nasdaq (Nasdaq: NDAQ) announced today the results of the semi-annual review of the OMX Iceland 15 Index, (Nasdaq Iceland: OMXI15), which will become effective at market... ► Artikel lesen | |
Mo | Bayer's Eylea market grip set to slip as Alvotech biosimilar closes in | 91 | Pharmaceutical Technology | ||
Mo | Kvika banki hf.: Transaction in relation to a share buy-back programme | 6 | GlobeNewswire (USA) | ||
Mo | Alvotech - 6-K, Report of foreign issuer | 3 | SEC Filings | ||
Mo | European Medicines Agency Recommends Market Approval of AVT06, Alvotech's Proposed Biosimilar to Eylea (aflibercept) | 324 | GlobeNewswire (Europe) | REYKJAVIK, Iceland and LONDON, June 23, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients... ► Artikel lesen | |
Fr | Kvika banki hf.: Assessment of the impact of the potential implementation of CRR III | 3 | GlobeNewswire (USA) | ||
Do | Kvika banki hf.: Offering of bonds on June 25 | 6 | GlobeNewswire (USA) |